John B Moriarty
CIK 1564621 · Chief Legal Officer · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$951.3K
Companies
6
Total Filings
58
Lifetime Open-Market Net
-$252.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KARD | Chief Legal Officer | 47,784 | — | — | $0 | 1 | 2026-06-22 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Chief Legal Officer | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Chief Legal Officer | 74,557 | $12.76 | $951.3K | -$252.8K | 5 | 2026-01-09 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Chief Legal Officer | 0 | $58.70 | $0 | $0 | 2 | 2024-01-23 |
| OLMA | EVP, Ch. Legal Officer & Sec. | — | $10.49 | — | $0 | 3 | 2023-02-02 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP, General Counsel | 0 | — | — | $0 | 7 | 2020-07-02 |
Recent Filings · Page 3 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-06 | OLMA | Notice (144) | −10,000 | -$59.5K | EDGAR |
| 2023-06-05 | OLMA | Notice (144) | −10,023 | -$60.4K | EDGAR |
| 2023-05-19 | OLMA | Notice (144) | −5,000 | -$35.8K | EDGAR |
| 2023-02-02 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2022-02-03 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2020-11-19 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Disp (D) | −12,893 | -$232.1K | EDGAR |
| 2020-03-03 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Tax (F) | −4,327 | -$41.9K | EDGAR |
| 2020-02-26 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Mixed | +12,706 | -$45.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.